Work

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase

Year: 2016

Type: article

Abstract: Significance New antifungal drugs that act via novel mechanisms are urgently needed to combat the high mortality of invasive fungal disease and the emergence of resistance to existing therapies. We describe the discovery, structure, activity, and mechanism of action of F901318, a new antifungal agent. A member of a novel class of antifungals, the orotomides, F901318 acts via inhibition of dihydroorotate dehydrogenase, an enzyme of de novo pyrimidine biosynthesis. F901318 is currently in clinical development for the treatment of invasive aspergillosis.

Source: Proceedings of the National Academy of Sciences

DOI: 10.1073/pnas.1608304113